Publication | Closed Access
Continued therapy with ABI-H0731+NRTI results in sequential reduction/loss of HBV DNA, HBV RNA, HBeAg, HBcrAg and HBsAg in HBeAg positive patients
13
Citations
0
References
2019
Year
Viral PersistenceViral HepatitisHematologyImmunologyHepatitisContinued TherapyAntiviral TherapyAbi-h0731+nrti ResultsChronic Viral InfectionHbv RnaMedicine
No additional data available for this publication yet. Check back later!